Inventor

MILLAN DAVID S

US47 patents

⚠️ This page may combine multiple inventors who share the name “MILLAN DAVID S”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MILLAN DAVID S

FORMA THERAPEUTICS INC

3-aryl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-spiro-7-hydroxamic acid tetralins as HDAC inhibitors

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

Tetrahydroquinoline compositions as BET bromodomain inhibitors

Benzopiperazine compositions as BET bromodomain inhibitors

Tetrahydroquinoline compositions as BET bromodomain inhibitors

Compounds and compositions for inhibition of FASN

Compounds and compositions for inhibition of FASN

Tetrahydroquinoline compositions as BET bromodomain inhibitors

Tetrahydroquinoline compositions as bet bromodomain inhibitors

Benzopiperazine compositions as BET bromodomain inhibitors

Compounds and compositions for inhibition of FASN

3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

Compounds and compositions for inhibition of FASN

Compounds and compositions for inhibition of FASN

Benzopiperazine compositions as BET bromodomain inhibitors

Benzopiperazine compositions as BET bromodomain inhibitors

Compounds and compositions for inhibition of FASN

VALO HEALTH INC

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

VALO EARLY DISCOVERY INC

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors